Kirill Osipov comments on regulation of dependent inventions in Russia

Kirill Osipov, the Head of Legal Department of ARS-Patent, commented on regulation of dependent inventions in Russia for the newspaper “Pharmvestnik” in the light of the Moscow Arbitration Court’s Decision of June 1, 2018, according to which, a first compulsory license may be granted in Russia to a medicament comprising INN Lenalidomide.

More details are available at Pharmvestnik’s website.

Pharmvestnik is the leading specialized weekly newspaper covering the Russian pharmaceutical and related industries with a circulation of 16 200 copies. The newspaper has been issued since 1994.

Make an enquiry

Latest News

ARS-Patent writes about new domestic regulations intended to fight evergreening of pharmaceutical patents

2019-05-14

Anna Pustogvar, patent expert at ARS-Patent, and Kirill Osipov, the Head of Legal Department of ARS-Patent, have been published in spring Newsletters ...

Read more
More about our presence in IP rankings

2019-04-08

Last week IP STARS published results of their extensive annual research on IP firms with the focus on patent practice. ARS-Patent is pleased to remain...

Read more

View all our News

MEET WITH US

Meet us at BIO 2019 in Philadelphia

2019-05-30

Meet Kirill Osipov, the Head of Legal Department at ARS-Patent, and Pavel Vorobev, patent attorney at ARS-Patent, at the BIO International Convention ...

Read more
Meet ARS-Patent at INTA 2019

2019-04-12

On May 18-22, 2019, ARS-Patent will attend the annual meeting of International Trademark Association (INTA), which will take place in Boston, Massachu...

Read more

See all Events

Back top